Michael Sadhra

Michael Sadhra is a declared insider of Algernon Pharmaceuticals Inc., with filings sourced from SEDI. The record holds 16 filings, for trades running from 17 October 2018 to 19 November 2021.

No open-market purchase appears, only 13 sales worth €75k. Outside the open market, there are 2 option exercises. Since January 2021: no purchases and 11 sales on the market.

Most recently, on 21 November 2021, the filings show an open-market sale worth €11k in Algernon Pharmaceuticals Inc. Filings reach the SEDI feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.